Evidence map›Paper›PMID 36085367›Full record

ArticlePediatric research2023

Metabolomic profiling of intrauterine growth-restricted preterm infants: a matched case-control study.

Elena Priante, Giovanna Verlato, Matteo Stocchero, Giuseppe Giordano, Paola Pirillo, Luca Bonadies, Silvia Visentin, Laura Moschino, Eugenio Baraldi

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Impact of Prematurity on Metabolic Maturation.Journal of proteome research · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elena PrianteDepartment of Women's and Children's Health, Neonatal Intensive Care Unit, University Hospital of Padua, Padua, Italy. elena.priante@aopd.veneto.it.ORCID http://orcid.org/0000-0002-4568-8166
Giovanna VerlatoDepartment of Women's and Children's Health, Neonatal Intensive Care Unit, University Hospital of Padua, Padua, Italy.
Matteo StoccheroInstitute of Pediatric Research, Città della Speranza, Laboratory of Mass Spectrometry and Metabolomics, Padua, Italy.
Giuseppe GiordanoInstitute of Pediatric Research, Città della Speranza, Laboratory of Mass Spectrometry and Metabolomics, Padua, Italy.
Paola PirilloInstitute of Pediatric Research, Città della Speranza, Laboratory of Mass Spectrometry and Metabolomics, Padua, Italy.
Luca BonadiesDepartment of Women's and Children's Health, Neonatal Intensive Care Unit, University Hospital of Padua, Padua, Italy.
Silvia VisentinDepartment of Women's and Children's Health, Unit of Gynecology and Obstetrics, University Hospital of Padua, Padua, Italy.
Laura MoschinoDepartment of Women's and Children's Health, Neonatal Intensive Care Unit, University Hospital of Padua, Padua, Italy.
Eugenio BaraldiDepartment of Women's and Children's Health, Neonatal Intensive Care Unit, University Hospital of Padua, Padua, Italy.
University of Padua · ITCittà della Speranza Foundation · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe biochemical variations occurring in intrauterine growth restriction (IUGR), when a fetus is unable to achieve its genetically determined potential, are not fully understood. The aim of this study is to compare the urinary metabolomic profile between IUGR and non-IUGR very preterm infants to investigate the biochemical adaptations of neonates affected by early-onset-restricted intrauterine growth.

methodsNeonates born <32 weeks of gestation admitted to neonatal intensive care unit (NICU) were enrolled in this prospective matched case-control study. IUGR was diagnosed by an obstetric ultra-sonographer and all relevant clinical data during NICU stay were captured. For each subject, a urine sample was collected within 48 h of life and underwent untargeted metabolomic analysis using mass spectrometry ultra-performance liquid chromatography. Data were analyzed using multivariate and univariate statistical analyses.

resultsAmong 83 enrolled infants, 15 IUGR neonates were matched with 19 non-IUGR controls. Untargeted metabolomic revealed evident clustering of IUGR neonates versus controls showing derangements of pathways related to tryptophan and histidine metabolism and aminoacyl-tRNA and steroid hormones biosynthesis.

conclusionsNeonates with IUGR showed a distinctive urinary metabolic profile at birth. Although results are preliminary, metabolomics is proving to be a promising tool to explore biochemical pathways involved in this disease. IMPACT: Very preterm infants with intrauterine growth restriction (IUGR) have a distinctive urinary metabolic profile at birth. Metabolism of glucocorticoids, sexual hormones biosynthesis, tryptophan-kynurenine, and methionine-cysteine pathways seem to operate differently in this sub-group of neonates. This is the first metabolomic study investigating adaptations exclusively in extremely and very preterm infants affected by early-onset IUGR. New knowledge on metabolic derangements in IUGR may pave the ways to further, more tailored research from a perspective of personalized medicine.

Indexed as

Infant, PrematureInfant, Premature, DiseasesCase-Control StudiesFemaleFetal Growth RetardationHormonesHumansInfant, NewbornPregnancyProspective StudiesTryptophanHormonesTryptophan

Identifiers

PMID36085367
OpenAlexW4295024108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.